{
  "retracted": false,
  "timestamp": 1433116800000,
  "updates": [
    {
      "timestamp": 1586593077273,
      "identifier": {
        "doi": "10.1016/j.urols.2015.06.290"
      },
      "type": "err"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.urols.2014.12.010"
  },
  "publisher": "Medknow",
  "title": "Corrigendum to “Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials” [Urol Sci (2015) 41–48]"
}
